Thin, Lena W Y <br/><br/>
Oral tacrolimus for the treatment of refractory inflammatory bowel disease in the biologic era.  [electronic resource] 

 -  Inflammatory bowel diseases  Jun 2013 
 - 1490-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1536-4844 
<br/><br/><label>Standard No.: </label>10.1097/MIB.0b013e318281f362  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adolescent<br/>Adult<br/>Biological Products--therapeutic use<br/>Colitis, Ulcerative--drug therapy<br/>Crohn Disease--drug therapy<br/>Drug Resistance--drug effects<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Male<br/>Prognosis<br/>Remission Induction<br/>Retrospective Studies<br/>Salvage Therapy<br/>Survival Rate<br/>Tacrolimus--therapeutic use<br/>Young Adult